Inventor · disambiguated record
Piraye Yurttas Beim
Also filed as: BEIM PIRAYE YURTTAS
4 granted patents·19 pending applications·12 citations·filing 2012–2025
71Inventor score
Top patents by PatentIndex Score
23 records- 0181US10580516B2Systems and methods for determining the probability of a pregnancy at a selected point in timeCELMATIX INC·Filed 2015·Granted Mar 3, 2020·2 cites·15 claims
- 0281US10208350B2Methods and systems for assessing infertility and related pathologiesCELMATIX INC·Filed 2015·Granted Feb 19, 2019·2 cites·17 claims
- 0380US9836577B2Methods and devices for assessing risk of female infertilityCELMATIX INC·Filed 2015·Granted Dec 5, 2017·2 cites·18 claims
- 0475US9177098B2Systems and methods for determining the probability of a pregnancy at a selected point in timeELASHOFF MICHAEL·Filed 2012·Granted Nov 3, 2015·6 cites·31 claims
- 0564US2019252043A1Systems and methods for determining the probability of a pregnancy at a selected point in timeCELMATIX INC·Filed 2019·Application pending·0 cites
- 0660US2020340059A1Methods and systems for assessing infertility as a result of declining ovarian reserve and functionCELMATIX INC·Filed 2019·Application pending·0 cites
- 0758US2020017912A1Methods and systems for assessing infertility and related pathologiesCELMATIX INC·Filed 2019·Application pending·0 cites
- 0850US2018218117A1Methods for assessing risk of female infertilityCELMATIX INC·Filed 2017·Application pending·0 cites
- 0948US2017107573A1Methods and systems for assessing infertility as a result of declining ovarian reserve and functionCELMATIX INC·Filed 2016·Application pending·0 cites
- 1047US2014171337A1Methods and devices for assessing risk of female infertilityCELMATIX INC·Filed 2013·Application pending·0 cites
- 1147US2022389069A1Compositions and methods regulating folliculogenesis for the treatment of ovarian senescenceCELMATIX INC·Filed 2020·Application pending·0 cites
- 1246US2019277856A1Methods for assessing risk of increased time-to-first-conceptionCELMATIX INC·Filed 2019·Application pending·0 cites
- 1346US2019295683A1Systems and methods for non-hormonal female contraceptive drug target identification and prioritizationCELMATIX INC·Filed 2019·Application pending·0 cites
- 1444US2025161269A1Compositions and methods for peripheral targeting of melatonin receptor agonistCELMATIX INC·Filed 2025·Application pending·0 cites
- 1541US2018108431A1Methods and systems for assessing fertility based on subclinical genetic factorsCELMATIX INC·Filed 2017·Application pending·0 cites
- 1640US2017351806A1Method for assessing fertility based on male and female genetic and phenotypic dataCELMATIX INC·Filed 2017·Application pending·0 cites
- 1739US2017262580A1Methods and systems for assessing infertility and ovulatory function disordersCELMATIX INC·Filed 2017·Application pending·0 cites
- 1839US2019080800A1Methods for assessing the potential for reproductive success and informing treatment therefromCELMATIX INC·Filed 2018·Application pending·0 cites
- 1939US2019027232A1System and method for processing electronic medical and genetic/genomic information using machine learning and other advanced analytics techniquesCELMATIX INC·Filed 2018·Application pending·0 cites
- 2038US2020011883A1Methods for assessing the probability of achieving ongoing pregnancy and informing treatment therefromCELMATIX INC·Filed 2018·Application pending·0 cites
- 2136US2015211068A1Methods for assessing whether a genetic region is associated with infertilityCELMATIX INC·Filed 2015·Application pending·0 cites
- 2234US2013109583A1Methods and devices for assessing risk to a putative offspring of developing a conditionBEIM PIRAYE YURTTAS·Filed 2012·Application pending·0 cites
- 2332US2017014456A1Methods and systems for endometrial treatmentCELMATIX INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Piraye Yurttas Beim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →